Amgen Inc. Form 8-K Filing

On July 29, 2026, Amgen Inc. reported a material cybersecurity incident involving unauthorized access to data stored in third-party cloud environments. The company identified that some of its data, including proprietary information, patient health information, and other sensitive data, was exfiltrated. Amgen has activated its cybersecurity response plan, engaged forensic experts, and is investigating the extent of the breach and its potential impact. Currently, there is no identified impact on Amgen's products, manufacturing operations, financial reporting, or ability to meet patient needs. The company is assessing the situation and will make all required regulatory and legal notifications, including to affected patients. While the incident is deemed material, Amgen does not believe it is reasonably likely to materially impact its financial condition or results of operations at this time. The investigation is ongoing.